Company news
Beijing Hotgen Biotech Co. Ltd. news in 2025
Beijing Hotgen Biotech Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Plan to Sell Part of Repurchased Shares through Call Auction Transactions
December 23, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
December 17, 2025
Announcement on Voluntary Disclosure of Recent Qualifications Obtained by the Joint-stock Company of the Company
December 2, 2025
Announcement on Joint Investment in Yaojing Gene with a Related Party and Related Party Transaction
December 1, 2025
Voluntary Disclosure Announcement on Designation as a National-Level "Little Giant" Enterprise (Specialized, Sophisticated, Distinctive, and Innovative)
November 24, 2025
Announcement on Voluntary Disclosure of Progress in the Share Repurchase through Call Auction
November 23, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 14, 2025
Announcement on Result of Shareholding Reduction by Controlling Shareholder
November 11, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
November 10, 2025
Announcement on Proposal of Canceling the 4th Extraordinary General Meeting in 2025
November 6, 2025
Announcement on Increasing the Estimated Amount for Daily Related Party Transactions in 2025
October 23, 2025
Announcement on Voluntary Disclosure of Positive Preliminary Results of the Phase Ib Clinical Study of the Innovative Drug SGC001 of the Joint-stock Company
October 22, 2025
Announcement on Change in Accounting Estimate
September 30, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 23, 2025
Announcement on Voluntary Disclosure of Recent Qualifications Obtained by the Company and Its Subsidiary
September 3, 2025
2025 Semi-annual Report
August 29, 2025
Announcement on Voluntary Disclosure of the Progress in Phase I Clinical Trial for Innovative Drug SGC001 of the Joint-Stock Company
August 28, 2025
Announcement on Shareholding Reduction Plan for Controlling Shareholders
August 14, 2025
Announcement on Result of Shareholding Reduction by Shareholders with Over 5% Shares
August 4, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
July 29, 2025
Resolutions of the 3rd Extraordinary General Meeting in 2025
July 4, 2025
Announcement on Share Reduction Plan for Shareholders with Over 5% Shares
June 25, 2025
Announcement on Reply to Letter of Regulatory Inquiry on Information Disclosure of 2024 Annual Report
June 20, 2025
Announcement on Term Change and Election of Board of Directors
June 17, 2025
Announcement on Completion of Shareholding Reduction Plan by Shareholder and Results of Share Reduction
June 5, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 22, 2025
Indicative Announcement on Shareholder's Equity Change Reaching 1%
May 19, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
May 12, 2025
Announcement on Voluntary Disclosure of Qualifications Obtained by the Company and Its Subsidiary
May 7, 2025
Announcement on Achievements of Vesting Conditions in the 3rd Vesting Period of the 1st Reserved Granted Part and the 2nd Vesting Period of the Reserved Granted Part under the 2020 Restricted Stock Incentive Plan
April 29, 2025